Latest Breaking News On - Tudy atorx se0000767188 - Page 1 : vimarsana.com

Alligator Bioscience has been off to a hot start in 2023. First came the positive interim results from the phase II study in pancreatic cancer. Then, the first patient was dosed in a phase I study for. | May 4, 2023

Financial supervisory authorityAlligator bioscienceBiostock investor pitchAlligator bioscience ab publ stock exchangePress releaseTudy atorx se0000767188